Management of Proximal Humerus Fractures in Adults: a Clinical Trial

Status Not yet recruiting

Clinical Trial Summary

Prospective patient registry examining the outcome of three different treatment methods for proximal humerus fractures in elderlies: conservative treatment, open and minimal invasive surgical treatment.

Clinical Trial Description

The present study shall be conducted in accordance with the SPIRIT 2013 statement: defining standard protocol items for clinical trials. All patients who sustained a PHF and presented at the Department of Orthopedics at the Academic Hospital of Bolzano (Italy) will be prospectively incited to participate in the present clinical trial. Patient recruitment will begin in April 2024, and end in April 2026. The follow-up period will start in October 2024, and end in April 2028. Data analysis will commence in October 2024 and end in April 2028. The present study shall be conducted according to the principles of the Declaration of Helsinki. The authors receive no financial support for the research, authorship, and/or publication of this article. The protocol of the study has been prospectively registered and approved by the German Registry of Clinical Trials (ID DRKS00030614). Ethics approval has been received from the Ethic Committee of the South Tyrolean Health Authority, Bolzano, Italy (ID 2022374 of June 22, 2023). All surgical and conservative procedures under analysis are already routinely carried out at the Department of Orthopaedics and Trauma Surgery of the Academic Hospital of Bolzano, Italy. Patients who meet the inclusion criteria and agree to participate in the study by signing the consent form and the personal data processing form will be included in the study. Data curation Personal data, including sensitive data, will be pseudonymised and associated with a code from which it will be impossible to trace the patient's identity. Only the Principal Investigator and sub-investigators of the study will be able to link the code to the name. The pseudonymised data will be collected in a table of Microsoft Office Excel version 16 (Microsoft Corporation, Redmond, US). Statistical analyses Assuming an actual difference in means between the test and reference group of 3 units and a pooled standard deviation of 5 units, the study would require a sample size of 117 patients for each group (i.e. a total sample size of 351, assuming equal group size), to obtain a power of 80% and a significance level of 5%, to declare the superiority of a technique with a margin of prominence of 5 units, assuming a minimum clinically important difference OSS of 2.7/100 . ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06360887
Study type	Observational [Patient Registry]
Source	Regional Hospital of Bolzano
Contact	Malte Nikolas Witte, Dr.
Phone	00393885787726
Email	maltewitte@posteo.de
Status	Not yet recruiting
Phase
Start date	April 2024
Completion date	January 31, 2028

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04003272` - MDR - Comprehensive Reverse/Versa Dial Ti Glenosphere
Active, not recruiting	`NCT02944058` - Plate Fixation Versus Intramedullary Nailing of 3 and 4 Part Proximal Humerus Fractures	N/A
Withdrawn	`NCT00741182` - Effect of PTH(1-34) Treatment on Fracture Healing in Vivo	Phase 2
Completed	`NCT03217344` - Conservative Treatment of Proximal Humeral Fractures	N/A
Recruiting	`NCT02609906` - Operative Treatment of 2-fragment-fractures (AO 11-A3) of the Proximal Humerus in the Elderly: Cement Augmented Locking Plate Philos vs. Proximal Humerus Nail MultiLoc	N/A
Active, not recruiting	`NCT05302089` - Rehabilitation Following Displaced Proximal Humerus Fractures	N/A
Completed	`NCT02836366` - Targon PH+ Follow-Up
Recruiting	`NCT01687374` - Parathyroid Hormone for the Treatment of Humerus Fractures	Phase 4
Recruiting	`NCT04928664` - Continuous vs Liposomal Bupivacaine Interscalene Block for Proximal Humeral Fracture (CLIP)	Phase 4
Completed	`NCT02539173` - Diagnosis of Diaphragmatic Paralysis After Interscalene Block: Feasibility and Impact Observed	N/A
Recruiting	`NCT04984291` - Zimmer Biomet Shoulder Arthroplasty PMCF	N/A
Not yet recruiting	`NCT06357143` - Efficacy of Early Multimodal Physiotherapy in Patients With Reverse Shoulder Prosthesis	N/A
Recruiting	`NCT02913378` - Conservative vs Surgical Treatment for Proximal Humerus Fractures in the Elderly	N/A
Enrolling by invitation	`NCT04003311` - MDR - Comprehensive Primary/Micro Stem & Versa-Dial Ti Humeral Head
Recruiting	`NCT04651543` - X-Ray Follow-up in Proximal Humeral Fractures Conservatively Treated
Recruiting	`NCT05084573` - Continuous Interscalene Block vs Liposomal Bupivacaine After Proximal Humerus Fracture Surgery	Phase 3
Not yet recruiting	`NCT04507880` - A 2-Year Prospective Follow-up Study of the Global Unite Reverse Fracture Shoulder System for Proximal Humerus Fractures	N/A
Terminated	`NCT03599336` - RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures	N/A
Recruiting	`NCT05284357` - Post Market Clinical Follow-up Study for Arthroplasty Shoulder System of FX Solutions at the Long Term

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.